COMPANY
Empower Clinic Services, LLC dba Empower Pharmacy
Empower Clinic Services, LLC dba Empower Pharmacy: warning letter recipient for Semaglutide, Tirzepatide, as stated by public registers.
WARNING LETTER RECIPIENT
Received an FDA warning letter naming the peptide.
| Semaglutide | CGMP/Finished Pharmaceuticals/Adulterated/Unapproved New Drug, 2026-09-18 Regulator FDA warning letters |
|---|---|
| Tirzepatide | CGMP/Finished Pharmaceuticals/Adulterated/Unapproved New Drug, 2026-09-18 Regulator FDA warning letters |
What a register states, not an endorsement or an accusation by this site. All companies.
WEEKLY
Register Watch, weekly
New trials, approvals and enforcement actions. One email a week.